logo
Primary immunodeficiency update
CME examination
Answers to CME examination
Primary immunodeficiency update
Answers to CME examination
CME examination
Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden
Commentary: Setting priorities for research funding at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis
Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study
Azathioprine treatment of intractable pruritus: A retrospective review
Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)
Combined cutaneous tumors with a melanoma component: A clinical, histologic, and molecular study
Immunosuppression is an independent prognostic factor associated with aggressive tumor behavior in cutaneous melanoma
Early-onset childhood vitiligo is associated with a more extensive and progressive course
Squaric acid sensitization is not required for response in the treatment of alopecia areata
A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules
Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients
Intradermal nevi with atypical nuclei in the elderly: The senescent nevus
Dysplastic nevus: Fact and fiction
Point: What's in a name?
Counterpoint: The “dysplastic” nevus
What costs nothing is worth nothing!
Identifying new biologic targets in atopic dermatitis (AD): A retrospective histologic analysis
Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale
Psoriasis and herpes simplex virus are highly stigmatizing compared with other common dermatologic conditions: A survey-based study
Reflections on smart phones, tablets, and ultraviolet (UV) light: Should we worry?
FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation
Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1
Correction
Scattered pruritic annular plaques with conchal bowl involvement
Blisters and erosions affecting the oral cavity, scalp, face, and trunk
Brown hyperpigmentation of the hands and chest in a patient with lung cancer and muscle weakness
Annular lesions predominantly located around a scar
Dermoscopy aids the diagnosis of crusted scabies in an erythrodermic patient
Darier disease: Dermoscopy, confocal microscopy, and histologic correlations
Different dermoscopic patterns of palmoplantar and nonpalmoplantar lichen nitidus
Nicotine staining of the hair and nails
Peristomal pyoderma gangrenosum (PG): A simple hydrocolloid dressing technique to promote wound healing
A simple method for maintaining control of sutures to prevent sharps injuries and protect aseptic conditions
Recreation of the alar crease using the inverted horizontal mattress suture technique
Could a simple microbiological culture and an antibiogram guide the treatment of our patients with papulopustular rosacea (PPR)?
Reply to: “Could a simple microbiological culture and an antibiogram guide the treatment of our patients with papulopustular rosacea?”
Should dermatopathologists disclose serious diagnostic errors to patients?
Reply: Medical error disclosure and patient compensation
Comment on “Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors”
Annual screening for tuberculosis in patients on TNF-alfa antagonists
Reply to: “Comment on ‘Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors’”
Iotaderma #259
August iotaderma (#258)